Figure 4From: Cetuximab and radiation for primary and recurrent squamous cell carcinoma of the head and neck (SCCHN) in the elderly and multi-morbid patient: a single-centre experienceOverall survival, n = 69 pts; Mean 23.1 months; 95% CI: 18.4 - 27.7 months.Back to article page